JP4904795B2 - Fatigue improver composition - Google Patents
Fatigue improver composition Download PDFInfo
- Publication number
- JP4904795B2 JP4904795B2 JP2005352088A JP2005352088A JP4904795B2 JP 4904795 B2 JP4904795 B2 JP 4904795B2 JP 2005352088 A JP2005352088 A JP 2005352088A JP 2005352088 A JP2005352088 A JP 2005352088A JP 4904795 B2 JP4904795 B2 JP 4904795B2
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- fatigue
- capsaicin
- taurine
- caffeine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 9
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims description 32
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 30
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 25
- 229960001948 caffeine Drugs 0.000 claims description 16
- 229960002504 capsaicin Drugs 0.000 claims description 16
- 235000017663 capsaicin Nutrition 0.000 claims description 16
- 229960003080 taurine Drugs 0.000 claims description 15
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 9
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 9
- 235000019156 vitamin B Nutrition 0.000 claims description 6
- 239000011720 vitamin B Substances 0.000 claims description 6
- 206010016256 fatigue Diseases 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000008213 purified water Substances 0.000 description 12
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 229940088594 vitamin Drugs 0.000 description 10
- 229930003231 vitamin Natural products 0.000 description 10
- 235000013343 vitamin Nutrition 0.000 description 10
- 239000011782 vitamin Substances 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 150000003722 vitamin derivatives Chemical class 0.000 description 9
- 229950001574 riboflavin phosphate Drugs 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 7
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 7
- 229940010454 licorice Drugs 0.000 description 7
- 244000000626 Daucus carota Species 0.000 description 6
- 235000002767 Daucus carota Nutrition 0.000 description 6
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 6
- 229940116257 pepper extract Drugs 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229960003966 nicotinamide Drugs 0.000 description 5
- 235000005152 nicotinamide Nutrition 0.000 description 5
- 239000011570 nicotinamide Substances 0.000 description 5
- 229940077082 red pepper extract Drugs 0.000 description 5
- -1 vitamin B2 phosphate ester Chemical class 0.000 description 5
- AEDORKVKMIVLBW-BLDDREHASA-N 3-oxo-3-[[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methoxy]oxan-2-yl]methoxy]propanoic acid Chemical compound OCC1=C(O)C(C)=NC=C1CO[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](COC(=O)CC(O)=O)O1 AEDORKVKMIVLBW-BLDDREHASA-N 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 4
- 235000011511 Diospyros Nutrition 0.000 description 4
- 244000236655 Diospyros kaki Species 0.000 description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 description 4
- 241000340987 Ptychopetalum olacoides Species 0.000 description 4
- 229940007061 capsicum extract Drugs 0.000 description 4
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 4
- 230000009182 swimming Effects 0.000 description 4
- 229940045613 taurine 1000 mg Drugs 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000238366 Cephalopoda Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 244000273928 Zingiber officinale Species 0.000 description 3
- 235000006886 Zingiber officinale Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000008397 ginger Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 3
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 3
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 3
- 229940089782 pyridoxine hydrochloride 5 mg Drugs 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 241000190633 Cordyceps Species 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- 241000195955 Equisetum hyemale Species 0.000 description 2
- 241000221017 Euphorbiaceae Species 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 208000019914 Mental Fatigue Diseases 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000270295 Serpentes Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 244000040738 Sesamum orientale Species 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 229940089133 vitamin b6 5 mg Drugs 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 1
- 241000271309 Aquilaria crassna Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000009113 Betula papyrifera Nutrition 0.000 description 1
- 235000009109 Betula pendula Nutrition 0.000 description 1
- 244000089654 Betula populifolia Species 0.000 description 1
- 235000010928 Betula populifolia Nutrition 0.000 description 1
- 235000002992 Betula pubescens Nutrition 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241001131796 Botaurus stellaris Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 235000002567 Capsicum annuum Nutrition 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241001527087 Panax vietnamensis Species 0.000 description 1
- 235000017726 Panax vietnamensis Nutrition 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000015724 Trifolium pratense Nutrition 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000316 bone substitute Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- PHIQHXFUZVPYII-UHFFFAOYSA-N carnitine Chemical compound C[N+](C)(C)CC(O)CC([O-])=O PHIQHXFUZVPYII-UHFFFAOYSA-N 0.000 description 1
- 229960000678 carnitine chloride Drugs 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 239000003818 cinder Substances 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229950006836 fursultiamine Drugs 0.000 description 1
- JTLXCMOFVBXEKD-FOWTUZBSSA-N fursultiamine Chemical compound C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N JTLXCMOFVBXEKD-FOWTUZBSSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229940023137 pyridoxine hydrochloride 20 mg Drugs 0.000 description 1
- 235000013526 red clover Nutrition 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
本発明は、スポーツや肉体労働に伴う疲労、徹夜等の不規則な生活に伴う疲労、または、ストレスに起因する精神的な疲労を改善するために有効な組成物に関し、医薬品、医薬部外品及び食品の分野で応用可能な発明である。 The present invention relates to a composition effective for improving fatigue associated with sports or physical labor, fatigue associated with irregular life such as staying up all night, or mental fatigue caused by stress. And an invention applicable in the field of food.
疲労は一種の生理現象で、スポーツや肉体労働に起因する疲労、徹夜等の不規則な生活に起因する疲労、またはストレスに起因する精神的な疲労など種々の態様の疲労が知られている。こうした疲労の軽減もしくは改善方法としては、休息や充分な睡眠、マッサージ、温泉療法などが挙げられるが、仕事に追われ、時間の取れない現代人が採る簡便な方法として、ビタミン含有保険薬の服用が挙げられる。 Fatigue is a kind of physiological phenomenon, and various forms of fatigue are known, such as fatigue caused by sports or physical labor, fatigue caused by irregular life such as staying up all night, or mental fatigue caused by stress. These methods of reducing or improving fatigue include rest, sufficient sleep, massage, and hot spring therapy, but taking vitamin-containing insurance drugs as a simple method for modern people who are busy with work and cannot take time. Is mentioned.
このビタミン含有保険薬には有効成分として、ビタミンB類、各種アミノ酸、カフェイン、生薬などが配合されているが(非特許文献1参照)、限られた配合量の中で前記各種疲労に対する充分な改善作用を奏するのは、なかなかに難しいことである。 This vitamin-containing insurance drug contains vitamin Bs, various amino acids, caffeine, herbal medicines, and the like as active ingredients (see Non-Patent Document 1). It is very difficult to achieve an improvement.
そこで、充分な安全性が確認され、各種疲労の改善に有効な薬剤等の開発が希求されていた。 Therefore, sufficient safety has been confirmed, and the development of drugs and the like effective for improving various fatigue has been demanded.
一方、トウガラシ(唐辛子)の辛味の主成分であるカプサイシン(capsaicin)は、体脂肪を燃焼させて肥満を防止したり、代謝を良くして持久力を増進させたり、炭水化物の消化を助けて便秘を解消し美肌作りに貢献したり、免疫賦活作用で発ガン抑制に寄与したりと種々の作用が知られているが(非特許文献2及び3参照)、疲労改善作用の増強に用いられたという報告はない。 On the other hand, capsaicin, the chief ingredient of red pepper, burns body fat to prevent obesity, improves metabolism and increases endurance, and helps digest carbohydrates and constipation It has been used to enhance fatigue-reducing effects, although it has been known to contribute to the creation of beautiful skin by eliminating the skin and contributing to the suppression of carcinogenesis by the immunostimulatory effect (see Non-Patent Documents 2 and 3). There is no report.
本発明の課題は、既存のビタミン含有保険薬に配合されているタウリン(2−アミノエタンスルホン酸)、ビタミンB類及びカフェインの有する疲労改善作用を増強し、安全で有効な疲労改善用組成物を提供することである。 An object of the present invention is to enhance the fatigue improving action of taurine (2-aminoethanesulfonic acid), vitamin Bs and caffeine, which are blended in an existing vitamin-containing insurance, and a safe and effective composition for improving fatigue. Is to provide things.
本発明者らは、上記課題を解決するために鋭意研究を重ねた結果、タウリン(2−アミノエタンスルホン酸)、ビタミンB類(ビタミンB2リン酸エステル、塩酸ピリドキシン、ニコチン酸アミド)及びカフェインを含有する液剤にカプサイシンを添加することにより、タウリン等の有する疲労改善作用が著しく増強されることを見出した。 As a result of intensive studies to solve the above problems, the present inventors have found that taurine (2-aminoethanesulfonic acid), vitamin Bs (vitamin B2 phosphate ester, pyridoxine hydrochloride, nicotinamide) and caffeine It has been found that the fatigue improving action of taurine or the like is remarkably enhanced by adding capsaicin to a liquid containing sucrose.
かかる知見に基づき完成した本発明の態様は、(a)2−アミノエタンスルホン酸、ビタミンB類及びカフェイン、並びに、(b)カプサイシン、を含有することを特徴とする疲労改善剤組成物である。 An aspect of the present invention completed based on such findings is a fatigue ameliorating agent composition comprising (a) 2-aminoethanesulfonic acid, vitamins B and caffeine, and (b) capsaicin. is there.
本発明により、タウリン、ビタミンB類及びカフェインの有する疲労改善作用が増強され、安全で有効な疲労改善剤組成物を提供することが可能となった。 According to the present invention, the fatigue improving action of taurine, vitamin Bs and caffeine is enhanced, and it is possible to provide a safe and effective fatigue improving agent composition.
本発明の疲労改善剤組成物は、2−アミノエタンスルホン酸、ビタミンB類及びカフェイン、並びに、カプサイシンを含んで構成されている。 The fatigue ameliorating agent composition of the present invention comprises 2-aminoethanesulfonic acid, vitamins B and caffeine, and capsaicin.
「2−アミノエタンスルホン酸(タウリン)」の有効投与量は成人(体重60kg)1日当たり200〜20,000mgである。 The effective dose of “2-aminoethanesulfonic acid (taurine)” is 200 to 20,000 mg per day for an adult (body weight 60 kg).
「ビタミンB類」としては、ビタミンB1、ビタミンB2、ビタミンB6、ビタミンB12及びビタミンB複合体が挙げられ、これらは塩やエステルであってもよい。例えば、塩酸チアミン、ビタミンB2リン酸エステル、塩酸ピリドキシン、ニコチン酸アミド、パントテン酸カルシウムが挙げられる。 Examples of “vitamin B” include vitamin B1, vitamin B2, vitamin B6, vitamin B12, and vitamin B complex, and these may be salts and esters. Examples include thiamine hydrochloride, vitamin B2 phosphate ester, pyridoxine hydrochloride, nicotinamide, and calcium pantothenate.
ビタミンB類の有効投与量は成人(体重60kg)1日当たり5〜500mgである。 The effective dose of vitamin B is 5 to 500 mg per day for adults (body weight 60 kg).
「カフェイン」の有効投与量は成人(体重60kg)1日当たり10〜1,000mgである。 The effective dose of “caffeine” is 10 to 1,000 mg per day for an adult (body weight 60 kg).
「カプサイシン(capsaicin)」とは、トウガラシ Capsicum annuum L. の果実中に、2%内外含有される辛味成分で、皮膚、粘膜などに塗布すると、その局所は血管が拡張され充血がみられる。消化管運動を亢進し少量で唾液、胃酸の分泌を促進するが、多量では逆に抑制する(薬科学大辞典より)。カプサイシンには、化学合成したり、天然物から抽出したカプサイシンそのものの他、トウガラシ等植物の原末、エキスに含有されている場合も含まれる。ここで、エキスの抽出溶媒としては、水、アルコール(メタノール、エタノール、プロパノール、イソプロパノール、ブタノールなど)、酢酸エチル、アセトン、ヘキサン、またはそれらの混液などが挙げられ、通常用いられる方法でエキスを製造することができる。 "Capsaicin" is a pungent component contained in capsicum annuum L., 2% inside and outside, and when applied to the skin, mucous membrane, etc., blood vessels are dilated and hyperemia is observed in the region. Increases gastrointestinal motility and promotes the secretion of saliva and gastric acid in small amounts, but conversely suppresses in large amounts (from the Pharmaceutical Sciences Dictionary). Capsaicin includes not only capsaicin which is chemically synthesized or extracted from natural products, but also contained in plant powders and extracts such as pepper. Here, the extraction solvent for the extract includes water, alcohol (methanol, ethanol, propanol, isopropanol, butanol, etc.), ethyl acetate, acetone, hexane, or a mixture thereof, and the extract is produced by a commonly used method. can do.
カプサイシンの有効投与量は成人(体重60kg)1日当たり、カプサイシン換算で0.01〜100mgである。 The effective dose of capsaicin is 0.01 to 100 mg in terms of capsaicin per day for an adult (body weight 60 kg).
本発明の疲労改善剤組成物は、タウリン、ビタミンB類、カフェイン及びカプサイシンを配合し、必要に応じて他の公知の添加剤、例えば、賦形剤、崩壊剤、結合剤、滑沢剤、抗酸化剤、コーティング剤、着色剤、矯味矯臭剤、界面活性剤、可塑剤等を添加して常法により、顆粒剤、散剤、カプセル剤、錠剤、ドライシロップ剤、液剤等の経口製剤として提供することができる。 The fatigue ameliorating agent composition of the present invention contains taurine, vitamin Bs, caffeine and capsaicin, and if necessary, other known additives such as excipients, disintegrants, binders, lubricants. , Antioxidants, coatings, coloring agents, flavoring agents, surfactants, plasticizers, etc., and provided as oral preparations such as granules, powders, capsules, tablets, dry syrups, and liquids by conventional methods can do.
また、必要に応じて他の生理活性成分、カリウム、カルシウム、マグネシウム、鉄、亜鉛等のミネラル、ビタミンA、C、D、E、K、P、葉酸、パントテン酸、リポ酸、ユビキノン等のビタミン類(誘導体も含む)、アルギニン、プロリン、バリン、ロイシン、イソロイシン、テアニン等のアミノ酸類、ホルモン、栄養成分、香料等を配合することにより、嗜好性をもたせることもできる。 If necessary, other physiologically active ingredients, minerals such as potassium, calcium, magnesium, iron and zinc, vitamins A, C, D, E, K, P, folic acid, pantothenic acid, lipoic acid, ubiquinone and other vitamins It is also possible to provide palatability by blending amino acids (including derivatives), amino acids such as arginine, proline, valine, leucine, isoleucine, and theanine, hormones, nutrients, and fragrances.
さらに、インヨウカク(イカリソウ)、茴香、エゾウコギ(刺五加、五加皮)、黄蓍、黄ゴン、黄精、黄連、遠志、何首烏、霍香、葛根、カノコソウ、乾姜、甘草、桔梗、枳実、羌活、枸杞子、枸杞葉、ケツジツ、桂皮、肉桂、桂枝、苦参、苦楝皮、玄参、紅花、紅参、香附子、厚朴、呉茱萸、胡麻、胡蘆巴、虎杖根、細辛、石榴、山梔子、山茱萸、山査子、鎖陽、山椒、山奈、山扁豆、山稜、酸棗仁、西洋山査子、生姜、縮砂、蛇床子、女貞子、芍薬、沙参、菖蒲根、升麻、地黄、熟地黄、沈香、川キュウ、川骨、川楝皮、蒼朮、菖蒲根、石斛、石菖根、蘇葉、蒼朮、大蒜、大棗、大豆(イソフラボンでも可)、沢瀉、竹節人参、茶葉、丁字(母丁香、公丁香)、陳皮、当帰、杜仲、党参、橙皮、人参、巴戟天、反鼻、麦門冬、白朮、ブラックコホッシュ、茯苓、覆盆子、防己、蒲公英、補骨脂、ムイラプアマ、木香、牡丹皮、レッドクローバー、ローズヒップ、益母草、益智、良姜、竜眼肉、ヨクイニン、ローヤルゼリー等を本発明の効果を損なわない範囲で配合することもできる。 In addition, Yakukaku (Ikarisou), Ayaka, Ezokogi (Sashigoka, Gokahide), Jaundice, Yellow Gon, Yellow spirit, Huang Ren, Distant, What neck, Ayaka, Kakkon, Kanokosou, Psoriasis, Licorice, Kikyo, Kakimi,羌活 、 枸杞 子 、 枸杞 葉 、 ケ ジ 、 桂皮 、 肉桂 、 桂枝 、 bittern, bitter rind, ginseng, safflower, red ginseng, garlic, Kobok, 茱萸 茱萸, sesame, cucumber, tiger cane, fine Spicy, sarcophagus, yam, yam, yam, yamako, chain yang, yam, yamana, yam, ridge, mountain ridge, soy sauce, western yam, ginger, shredded sand, snake bed, sadako, glaze, sasan, sone, sesame, Ground yellow, maturity yellow, agarwood, river cucumber, river bone, river husk, persimmon, root, stalagmite, sarcophagus, soba, persimmon, large persimmon, large persimmon, soybean (isoflavone is also acceptable), saw potato, bamboo ginseng, tea leaves , Cing (mother cinder, public cicada), Chen leather, Toki, Tochu, Party ginseng, Orange peel, Carrot, Brahma, Anti-nose, Mumon winter, White birch, Bra The effects of the present invention are impaired in the effects of the present invention such as wolfberry, cocoon, bon bonsai, self-prevention, Koei Sakaki, bone substitute, muirapuama, wood incense, peony skin, red clover, rose hips, benevolent grass, masochist, ryokan, longan meat, yakuinin, royal jelly, etc. It can also be blended in a range not included.
以下に実施例及び試験例を挙げ、本発明をさらに詳細に説明する。なお、生薬の配合量は原生薬換算量を示す。 Hereinafter, the present invention will be described in more detail with reference to examples and test examples. The compounding amount of the crude drug represents the equivalent amount of the drug substance.
実施例1
タウリン 4000 mg
ビタミンB2リン酸エステル 20 mg
塩酸ピリドキシン 20 mg
ニコチン酸アミド 80 mg
無水カフェイン 200 mg
カプサイシン 200 mg
上記に示す量のタウリン、ビタミンB2リン酸エステル、塩酸ピリドキシン、ニコチン酸アミド及び無水カフェインを180mLの精製水に溶解させたのち、適量のエタノールに溶解させたカプサイシンを加え、さらに精製水により200mLにメスアップして、液剤を得た。
Example 1
Taurine 4000 mg
Vitamin B2 phosphate 20 mg
Pyridoxine hydrochloride 20 mg
Nicotinamide 80 mg
Capsaicin 200 mg
After dissolving taurine, vitamin B 2 phosphate ester, pyridoxine hydrochloride, nicotinamide and anhydrous caffeine in the amounts shown above in 180 mL of purified water, add capsaicin dissolved in an appropriate amount of ethanol, and further with purified water. The volume was made up to 200 mL to obtain a solution.
実施例2
タウリン 1000 mg
ビタミンB1硝酸塩 5 mg
ビタミンB2リン酸エステル 5 mg
ビタミンB6 5 mg
イノシトール 50 mg
ニコチン酸アミド 20 mg
無水カフェイン 50 mg
トウガラシエキス 50 μL
上記に示す量のトウガラシエキスを除く成分を90mLの精製水に溶解させたのち、トウガラシエキスを加え、さらに精製水により100mLにメスアップして、液剤を得た。
Example 2
Taurine 1000 mg
Vitamin B1 nitrate 5 mg
Vitamin B2 phosphate 5 mg
Vitamin B6 5 mg
Inositol 50 mg
Nicotinamide 20 mg
Anhydrous caffeine 50 mg
Red pepper extract 50 μL
Components other than the above-mentioned amount of red pepper extract were dissolved in 90 mL of purified water, then red pepper extract was added, and further diluted to 100 mL with purified water to obtain a solution.
実施例3
タウリン 2000 mg
塩酸フルスルチアミン 7 mg
ビタミンB2リン酸エステル 5 mg
ビタミンB6 5 mg
イノシトール 50 mg
ニコチン酸アミド 30 mg
塩化カルニチン 50 mg
無水カフェイン 50 mg
トウガラシエキス 100 μL
上記に示す量のトウガラシエキスを除く成分を90mLの精製水に溶解させたのち、トウガラシエキスを加え、さらに精製水により100mLにメスアップして、液剤を得た。
Example 3
Taurine 2000 mg
Fursultiamine hydrochloride 7 mg
Vitamin B2 phosphate 5 mg
Vitamin B6 5 mg
Inositol 50 mg
Nicotinamide 30 mg
Carnitine chloride 50 mg
Anhydrous caffeine 50 mg
Components other than the above-mentioned amount of red pepper extract were dissolved in 90 mL of purified water, then red pepper extract was added, and further diluted to 100 mL with purified water to obtain a solution.
実施例4
タウリン 1000 mg
ビタミンB2リン酸エステル 5 mg
塩酸ピリドキシン 5 mg
無水カフェイン 50 mg
イカリ草 1000 mg
トウキ(当帰) 50 mg
ニンジン(人参) 600 mg
オウギ(黄耆) 600 mg
カンゾウ(甘草) 150 mg
オウセイ(黄精) 600 mg
タイソウ(大棗) 300 mg
ショウキョウ(生姜) 75 mg
サイコ(柴胡) 150 mg
ハンピ(反鼻) 250 mg
ムイラプアマ 300 mg
トウガラシエキス 100 μL
上記に示す量のトウガラシエキスを除く成分を45mLの精製水に溶解させたのち、トウガラシエキスを加え、さらに精製水により50mLにメスアップして、液剤を得た。
Example 4
Taurine 1000 mg
Vitamin B2 phosphate 5 mg
Pyridoxine hydrochloride 5 mg
Anhydrous caffeine 50 mg
Touki (Today) 50 mg
Carrot (carrot) 600 mg
Ougi (Twilight) 600 mg
Licorice (licorice) 150 mg
Horsetail (yellow spirit) 600 mg
Taisou 300mg
Ginger (ginger) 75 mg
Psycho (Shibako) 150 mg
Hampi (antinasal) 250 mg
The components excluding the above-mentioned amount of pepper extract were dissolved in 45 mL of purified water, added with pepper extract, and further diluted to 50 mL with purified water to obtain a solution.
実施例5
タウリン 1000 mg
ビタミンB2リン酸エステル 5 mg
塩酸ピリドキシン 5 mg
無水カフェイン 50 mg
ロクジョウ(鹿茸) 300 mg
イカリ草 1000 mg
トウチュウカソウ(冬虫夏草) 150 mg
クコシ(枸杞子) 200 mg
ジオウ(地黄) 200 mg
トウキ(当帰) 200 mg
ニンジン(人参) 600 mg
オウギ(黄耆) 300 mg
カンゾウ(甘草) 150 mg
オウセイ(黄精) 300 mg
ブクリョウ(茯苓) 300 mg
ケイヒ(桂皮) 150 mg
ハンピ(反鼻) 300 mg
ムイラプアマ 300 mg
トウガラシエキス 100 μL
上記に示す量のトウガラシエキスを除く成分を45mLの精製水に溶解させたのち、トウガラシエキスを加え、さらに精製水により50mLにメスアップして、液剤を得た。
Example 5
Taurine 1000 mg
Vitamin B2 phosphate 5 mg
Pyridoxine hydrochloride 5 mg
Anhydrous caffeine 50 mg
Euphorbiaceae (Cycium Cordyceps) 150 mg
Giant (ground yellow) 200 mg
Touki (home delivery) 200 mg
Carrot (carrot) 600 mg
Ougi (Twilight) 300 mg
Licorice (licorice) 150 mg
Horsetail (yellow spirit) 300 mg
Bukuryo (茯苓) 300 mg
Keihi (cinnamon) 150 mg
Hampi (antinasal) 300 mg
The components excluding the above-mentioned amount of pepper extract were dissolved in 45 mL of purified water, added with pepper extract, and further diluted to 50 mL with purified water to obtain a solution.
実施例6
タウリン 1000 mg
ビタミンB2リン酸エステル 5 mg
塩酸ピリドキシン 5 mg
無水カフェイン 50 mg
ロクジョウ(鹿茸) 300 mg
イカリ草 1000 mg
トウチュウカソウ(冬虫夏草) 300 mg
トチュウ(杜仲) 300 mg
ニクジュヨウ 500 mg
トシシ(菟糸子) 300 mg
ジャショウシ(蛇床子) 300 mg
カイクジン(海狗腎) 100 mg
ジオウ(地黄) 300 mg
ニンジン(人参) 600 mg
カンゾウ(甘草) 100 mg
サンヤク(山薬) 300 mg
ゴミシ(五味子) 300 mg
サンシュユ(山茱萸) 500 mg
ブクリョウ(茯苓) 300 mg
ハンピ(反鼻) 250 mg
ムイラプアマ 300 mg
トウガラシエキス 100 μL
上記に示す量のトウガラシエキスを除く成分を45mLの精製水に溶解させたのち、トウガラシエキスを加え、さらに精製水により50mLにメスアップして、液剤を得た。
Example 6
Taurine 1000 mg
Vitamin B2 phosphate 5 mg
Pyridoxine hydrochloride 5 mg
Anhydrous caffeine 50 mg
Euphorbiaceae (Cycium Cordyceps) 300 mg
Toshishi (boiled silkworm) 300 mg
Jashoushi (snake bed) 300 mg
Kaikujin (sea shark kidney) 100 mg
Giant (ground yellow) 300 mg
Carrot (carrot) 600 mg
Licorice (licorice) 100 mg
Sanyaku (Yakuyaku) 300 mg
Garbage (Gomiko) 300 mg
Bukuryo (茯苓) 300 mg
Hampi (antinasal) 250 mg
The components excluding the above-mentioned amount of pepper extract were dissolved in 45 mL of purified water, added with pepper extract, and further diluted to 50 mL with purified water to obtain a solution.
試験例1
ddY系雄性マウス(4週齢、日本エスエルシー株式会社から購入)に下表1に記載の液剤を14日間反復経口投与した後に、マウスの体重の8質量%に相当する錘をつけて水温を10℃に維持した水槽中で強制遊泳させて、5秒以上沈むまでの時間を測定した。なお、1群当たりのマウスは15匹で実験を行った。
Test example 1
After repeated oral administration of the solutions shown in Table 1 below to ddY male mice (4 weeks old, purchased from Japan SLC Co., Ltd.) for 14 days, a weight corresponding to 8% by mass of the body weight of the mice is attached and the water temperature is adjusted. After forced swimming in a water tank maintained at 10 ° C., the time until sinking for 5 seconds or more was measured. The experiment was performed with 15 mice per group.
各群の平均遊泳時間、標準誤差及び群間の有意差検定結果は図1に示したとおりである。本発明にかかる薬剤Cは、薬剤A及びBに比し遊泳時間が長く、優れた疲労改善作用を有することが示唆された。 The average swimming time of each group, the standard error, and the significant difference test result between groups are as shown in FIG. It was suggested that the drug C according to the present invention has a longer swimming time than the drugs A and B and has an excellent fatigue improving action.
本発明により、安全で、有効な疲労改善作用を有する医薬品、医薬部外品及び食品の開発が期待される。 According to the present invention, development of safe, effective pharmaceuticals, quasi-drugs and foods having an effect of improving fatigue is expected.
Claims (1)
A fatigue improver composition comprising (a) 2-aminoethanesulfonic acid, vitamins B and caffeine, and (b) capsaicin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005352088A JP4904795B2 (en) | 2005-12-06 | 2005-12-06 | Fatigue improver composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005352088A JP4904795B2 (en) | 2005-12-06 | 2005-12-06 | Fatigue improver composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007153816A JP2007153816A (en) | 2007-06-21 |
JP4904795B2 true JP4904795B2 (en) | 2012-03-28 |
Family
ID=38238621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005352088A Active JP4904795B2 (en) | 2005-12-06 | 2005-12-06 | Fatigue improver composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4904795B2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5010879B2 (en) * | 2006-09-07 | 2012-08-29 | 常盤薬品工業株式会社 | Liquid composition |
JP5620647B2 (en) * | 2009-01-30 | 2014-11-05 | ハウス食品グループ本社株式会社 | Sleepiness alarm composition |
US9040082B2 (en) * | 2011-06-24 | 2015-05-26 | K-Pax Pharmaceuticals, Inc. | Compositions and methods for treatment of chronic fatigue |
DE102013109911A1 (en) * | 2013-09-10 | 2015-03-12 | Kurt Putz | Oral administration form containing a mixture of solid stimulants and herbal extracts of traditional Chinese medicine |
KR101625927B1 (en) * | 2014-09-03 | 2016-05-31 | 주식회사 이에스바이오텍 | Functional Food including capsanthin having enhanced capacities of spontaneous locomotor activity and anti-fatigue activity |
WO2016130942A1 (en) * | 2015-02-12 | 2016-08-18 | Blue Dragonfly, Inc. | Compositions providing extended energy and methods of use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11217329A (en) * | 1998-01-30 | 1999-08-10 | Sanpo Seiyaku Kk | Solidified analeptic |
JP4163631B2 (en) * | 2003-01-28 | 2008-10-08 | 森永製菓株式会社 | Fermentation composition of spicy varieties of chili pepper and its use |
-
2005
- 2005-12-06 JP JP2005352088A patent/JP4904795B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2007153816A (en) | 2007-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4904795B2 (en) | Fatigue improver composition | |
JPH11500725A (en) | Use of piperine as a bioavailability enhancer | |
CN102670763A (en) | Composition with auxiliary protection effect on chemical liver injury and preparation method of composition | |
CN105126067A (en) | Composition for reducing uric acid and application thereof | |
JP2016102111A (en) | Pharmaceutical compositions considered as supplementary chemotherapy pharmaceuticals and applications thereof | |
KR20100036820A (en) | The invigorate energy food which is made from herb medicine and the producing method thereof | |
JP4397663B2 (en) | Muscle mass increasing agent | |
JP2019081794A (en) | Gastrointestinal agent composition | |
JP5118863B2 (en) | Hypnotic pharmaceutical composition | |
CN104013817A (en) | Conic gymnadenia tuber-sealwort-radix polygonati officinalis preparation and production method thereof | |
KR101989739B1 (en) | Composition for preventing or treating diabetes mellitus comprising Rorippa globosa extracts | |
JP2007161643A (en) | Prophylactic or ameliorating agent for pms | |
RU2240131C1 (en) | Agent "artrovit" for prophylaxis and treatment of arthritis and arthrosis | |
KR102322276B1 (en) | Beverage composition for preventing obesity and relieving edema | |
CN102106999A (en) | Chinese medicinal compound preparation for treating dysphagia due to stroke and preparation method thereof | |
IT201800003814A1 (en) | FORMULATION BASED ON COFFEE POWDER | |
KR20010009653A (en) | Composition for treating sexual dysfunction | |
CN103920023A (en) | Traditional Chinese medicine for treating hypertension | |
CN109331129A (en) | A kind of Chinese medicine dietary product and preparation method thereof suitable for the proliferation of mammary gland | |
CN103598588B (en) | A kind of health food with improving water flood effect | |
KR20010019397A (en) | Composition for sexual dysfunction | |
KR20190044289A (en) | Compositions for preventing or treating depression comprising extracts of Xanthii fructus | |
CN113181205B (en) | Pharmaceutical composition comprising NMN and use thereof | |
JPH06107553A (en) | Composition having analgesic function | |
CN105687985A (en) | Psoralea corylifolia oral liquid for spleen warming and diarrhea stopping, and production method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20081111 |
|
RD07 | Notification of extinguishment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7427 Effective date: 20090624 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111213 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111226 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150120 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4904795 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150120 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |